Higher rates of skin clearance and efficacy in challenging body areas are associated with better health‐related quality of life following ixekizumab maintenance treatment in pediatric patients with plaque psoriasis

BACKGROUND/OBJECTIVES: Information is limited on the relationship between skin clearance, resolution of challenging body areas, and improvement of patient‐reported outcomes (PROs) in pediatric psoriasis. Ixekizumab, a high‐affinity monoclonal antibody that selectively targets interleukin‐17A, is app...

Descripción completa

Detalles Bibliográficos
Autores principales: Hebert, Adelaide A., Bobonich, Margaret A., Rodriguez Capriles, Claudia, Gallo, Gaia, Li, Lingnan, Somani, Najwa, Ridenour, Terri, Wang, Yan, Edson‐Heredia, Emily, Becker, Emily M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299936/
https://www.ncbi.nlm.nih.gov/pubmed/34931346
http://dx.doi.org/10.1111/pde.14892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299936/
https://www.ncbi.nlm.nih.gov/pubmed/34931346
http://dx.doi.org/10.1111/pde.14892

Ejemplares similares